Exelixis
EXEL
#2109
Rank
A$11.30 B
Marketcap
$39.63
Share price
-1.53%
Change (1 day)
18.25%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: A$11.30 Billion

As of September 2024 Exelixis has a market cap of A$11.30 Billion. This makes Exelixis the world's 2109th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2024

End of year Market Cap

Year Market cap Change
2024A$11.30 B3.23%
2023A$10.95 B44.02%
2022A$7.60 B-4.42%
2021A$7.95 B-1.56%
2020A$8.08 B6.1%
2019A$7.61 B-9.01%
2018A$8.37 B-27.35%
2017A$11.52 B92.1%
2016A$5.99 B239.76%
2015A$1.76 B413.09%
2014A$0.34 B-72.88%
2013A$1.26 B56.63%
2012A$0.80 B29.34%
2011A$0.62 B-29.36%
2010A$0.88 B-0.34%
2009A$0.88 B15.86%
2008A$0.76 B-25.8%
2007A$1.03 B-5.6%
2006A$1.09 B2.06%
2005A$1.07 B16.63%
2004A$0.92 B36.15%
2003A$0.67 B-19.81%
2002A$0.84 B-53.88%
2001A$1.82 B49.59%
2000A$1.22 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Exelixis was reported to be:

A$11.30 Billion
by Yahoo Finance info icon info icon
A$11.30 Billion
by CompaniesMarketCap info icon info icon
A$11.30 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
A$126.66 B 1,020.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$216.68 B 1,816.99%๐Ÿ‡ซ๐Ÿ‡ท France
A$445.46 B 3,840.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$150.24 B 1,229.21%๐Ÿ‡บ๐Ÿ‡ธ USA
A$271.90 B 2,305.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$592.71 B 5,143.55%๐Ÿ‡บ๐Ÿ‡ธ USA
A$250.05 B 2,112.13%๐Ÿ‡บ๐Ÿ‡ธ USA
A$52.99 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.78 B-93.08%๐Ÿ‡บ๐Ÿ‡ธ USA